First-Line Treatment for Advanced Non-squamous Non-Small-Cell Lung Cancer With Negative Driver Gene: a Single-center, Single-Arm Trial
NCT05648071
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Advanced Non-squamous Non-Small-Cell Lung Cancer
Interventions
DRUG:
Sintilimab
Sponsor
Qianfoshan Hospital